(Q36620652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Pharmacological management of mood and anxiety disorders in headache patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Maryam Razavi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

46 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

S133-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034391%20AND%20SRC:MED&resulttype=core&format=json

Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

General principles of migraine management: the changing role of prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

The efficacy and safety of venlafaxine in the prophylaxis of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Migraine headache prophylaxis and treatment with low-dose mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Nefazodone for chronic daily headache prophylaxis: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

21 January 2018

Neuroleptics in headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Olanzapine in the treatment of refractory migraine and chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Olanzapine as an abortive agent for cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X

Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00564.X